Familial Hypomagnesemia with Hypercalciuria, Nephrocalcinosis, and Bilateral Chorioretinal Atrophy in a Patient with Homozygous p.G75S Variant in CLDN19

Abstract

Introduction Familial hypomagnesemia with hypercalciuria and nephrocalcinosis (FHHNC) is a rare disorder caused by perturbation in renal reabsorption of magnesium and calcium. Biallelic pathogenic variants either in gene CLDN16 or CLDN19 are responsible for molecular defects. Most patients with CLDN19 variants have been associated with ocular involvements (FHHNCOI).

Patient and Methods We had a pediatric patient with hypercalciuric hypomagnesemia and bilateral chorioretinal atrophy. Metabolic profiling and radiology examinations were performed, in addition to whole exome sequencing (WES) used for detection of the causative variant.

Results Analysis of WES revealed a homozygous c.223G > A (p.G75S) variant in CLDN19. MutationTaster and Combined Annotation-Dependent Depletion support its deleterious effect and SHERLOC's criteria put it in pathogenic category. This variant is previously reported in compound heterozygous state with other known pathogenic variant. As far as we know, it is the first report of this variant in homozygous state.

Conclusion The variant found in our patient is pathogenic and compatible with FHHNCOI characteristics. WES is an advantageous tool in molecular diagnosis and finding genetic pathology of this disease. In line with other reports, ocular abnormalities are variable in patients with CLDN19 mutations, and chronic kidney disease and retinal damages must be considered in this group.

Keywords

WES - hypomagnesemia - hypercalciuria - chorioretinal atrophy - CLDN19

Publication History

Received: 27 January 2020

Accepted: 28 March 2020

Article published online:
26 July 2021

• References

• 1 Hou J, Goodenough DA. Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens 2010; 19 (05) 483-488
• 2 Viering DHHM, de Baaij JHF, Walsh SB, Kleta R, Bockenhauer D. Genetic causes of hypomagnesemia, a clinical overview. Pediatr Nephrol 2017; 32 (07) 1123-1135
• 3 Faller N, Dhayat NA, Fuster DG. Nephrolithiasis secondary to inherited defects in the thick ascending loop of Henle and connecting tubules. Urolithiasis 2019; 47 (01) 43-56
• 4 Yamaguti PM, Neves FA, Hotton D. et al. Amelogenesis imperfecta in familial hypomagnesaemia and hypercalciuria with nephrocalcinosis caused by CLDN19 gene mutations. J Med Genet 2017; 54 (01) 26-37
• 5 Bardet C, Courson F, Wu Y. et al. Claudin-16 deficiency impairs tight junction function in ameloblasts, leading to abnormal enamel formation. J Bone Miner Res 2016; 31 (03) 498-513
• 6 Lv F, Xu XJ, Wang JY. et al. A novel mutation in CLDN16 results in rare familial hypomagnesaemia with hypercalciuria and nephrocalcinosis in a Chinese family. Clin Chim Acta 2016; 457: 69-74
• 7 Sim NL, Kumar P, Hu J, Henikoff S, Schneider G, Ng PC. SIFT web server: predicting effects of amino acid substitutions on proteins. Nucleic Acids Res. 2012 ;40(Web Server issue):W452–7
• 8 Schwarz JM, Cooper DN, Schuelke M, Seelow D. MutationTaster2: mutation prediction for the deep-sequencing age. Nat Methods 2014; 11 (04) 361-362
• 9 Adzhubei IA, Schmidt S, Peshkin L. et al. A method and server for predicting damaging missense mutations. Nat Methods 2010; 7 (04) 248-249
• 10 Rentzsch P, Witten D, Cooper GM, Shendure J, Kircher M. CADD: predicting the deleteriousness of variants throughout the human genome. Nucleic Acids Res 2019; 47 (D1): D886-D894
• 11 Waterhouse A, Bertoni M, Bienert S. et al. SWISS-MODEL: homology modelling of protein structures and complexes. Nucleic Acids Res 2018; 46 (W1): W296-W303
• 12 Richards S, Aziz N, Bale S. et al; ACMG Laboratory Quality Assurance Committee. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genet Med 2015; 17 (05) 405-424
• 13 Nykamp K, Anderson M, Powers M. et al; Invitae Clinical Genomics Group. Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria. Genet Med 2017; 19 (10) 1105-1117
• 14 Claverie-Martín F, García-Nieto V, Loris C. et al; RenalTube Group. Claudin-19 mutations and clinical phenotype in Spanish patients with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. PLoS One 2013; 8 (01) e53151
• 15 Konrad M, Schaller A, Seelow D. et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet 2006; 79 (05) 949-957
• 16 Wang SB, Xu T, Peng S. et al. Disease-associated mutations of claudin-19 disrupt retinal neurogenesis and visual function. Commun Biol 2019; 2: 113
• 17 Peng S, Wang SB, Singh D. et al. Claudin-3 and claudin-19 partially restore native phenotype to ARPE-19 cells via effects on tight junctions and gene expression. Exp Eye Res 2016; 151: 179-189
• 18 Horinouchi T, Nozu K, Kamiyoshi N. et al. Diagnostic strategy for inherited hypomagnesemia. Clin Exp Nephrol 2017; 21 (06) 1003-1010